Ng George K

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

4
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Processa Pharmaceuticals, Inc.Chief Executive OfficerOption exercisenothing paid1,600 sharesAug 11, 2026Processa Pharmaceuticals, Inc.Chief Executive Officernothing paidExercise · Aug 11Option exercise1,600Aug 11, 2026
Processa Pharmaceuticals, Inc.Chief Executive OfficerOption exercise—1,600 sharesAug 11, 2026Processa Pharmaceuticals, Inc.Chief Executive Officer—Exercise · Aug 11Option exercise1,600Aug 11, 2026
Processa Pharmaceuticals, Inc.Chief Executive OfficerAwardnothing paid9,384 sharesJul 28, 2026Processa Pharmaceuticals, Inc.Chief Executive Officernothing paidAward · Jul 28Award9,384Jul 28, 2026
Processa Pharmaceuticals, Inc.Chief Executive OfficerOpen-market buy$5,9003,057 sharesJul 1, 2026Processa Pharmaceuticals, Inc.Chief Executive Officer$5,900Buy · Jul 1Open-market buy3,057Jul 1, 2026